Blind intra-articular injection with low- and high-dose corticosteroid in adhesive capsulitis: a randomized, double-blind, controlled trial
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0001451
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 94
(1) Age, 20 to 70 years old
(2) stage 2 (freezing stage) of adhesive capsulitis at least 1 month of pain duration: pain and stiffness in predominantly one shoulder for =1 months
(3) average pain intensity during a day defined as a score of 5 points or more on a 10-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain)
(1) Secondary adhesive capsulitis (suspicious of secondary to other causes including inflammatory, metabolic, or infectious arthritis; cerebrovascular accident; tumor; or fracture)
(2) Definite rotator cuff lesion; complete or full-thickness tear of the rotator cuff
(3) Previous corticosteroid injection at the affected shoulder within 1 month
(4) High-risk bleeding tendency; taking medication such as an anticoagulant with the exception of those who agreed to stop for a minimum of 5 days before the injection.
(5) Uncontrolled serum glucose level in diabetes patient (>180mg/dl)
(6) Previous history of shoulder surgery
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Shoulder pain and disability index
- Secondary Outcome Measures
Name Time Method Overall shoulder pain using a visual analog scale;Passive range of motion of shoulder